{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:48:57Z","timestamp":1781423337563,"version":"3.54.1"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Replication-competent retrovirus (RCR) vectors are intrinsically incapable of infecting quiescent cells and have been shown to achieve highly efficient and tumor-restricted replicative spread and gene transfer in vivo after direct intratumoral injection in a variety of primary cancer models. However, i.v. delivery of RCR vectors expressing therapeutic genes has never previously been tested, particularly in an immunocompetent tumor model. Therefore, in the present study, we sought to test the therapeutic effect of an RCR vector (ACE-CD) carrying the yeast cytosine deaminase (CD) gene, which converts the nontoxic prodrug 5-fluorocytosine (5FC) into the chemotoxin 5-fluorouracil, after delivery by infusion into the locoregional circulation in a multifocal hepatic metastasis model of colon cancer. After confirmation of suicide gene cytotoxicity in vitro, multifocal hepatic tumors were established in syngeneic mice with murine CT26 colorectal cancer cells expressing firefly luciferase (CT26-Luc), and the ACE-CD vector was infused via intrasplenic injection into the portal circulation. Fourteen days after locoregional infusion, systemic administration of 5FC resulted in significant inhibition of bioluminescent signals in mice whose tumors had been infected with RCR but not in control mice. Notably, there was no detectable RCR vector spread to normal liver or bone marrow by quantitative PCR analysis. Our results thus show that locoregional delivery of a suicide gene by RCR vectors infused into the portal circulation results in progressive transduction of multiple tumor foci in the liver, without evidence of spread to adjacent normal parenchyma or extrahepatic tissues, and can achieve significant tumor growth inhibition. [Cancer Res 2007;67(11):5345\u201353]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4673","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T22:28:14Z","timestamp":1180736894000},"page":"5345-5353","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Therapeutic Efficacy of Replication-Competent Retrovirus Vector\u2013Mediated Suicide Gene Therapy in a Multifocal Colorectal Cancer Metastasis Model"],"prefix":"10.1158","volume":"67","author":[{"given":"Kei","family":"Hiraoka","sequence":"first","affiliation":[{"name":"1Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"1Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Logg","sequence":"additional","affiliation":[{"name":"1Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Kuo","family":"Tai","sequence":"additional","affiliation":[{"name":"1Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Haga","sequence":"additional","affiliation":[{"name":"1Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Lawson","sequence":"additional","affiliation":[{"name":"2Division of Laboratory Animal Medicine, University of California Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kasahara","sequence":"additional","affiliation":[{"name":"1Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,6,1]]},"reference":[{"key":"2022061623212553400_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin\u20082006; 56: 106\u201330.","DOI":"10.3322\/canjclin.56.2.106"},{"key":"2022061623212553400_B2","doi-asserted-by":"crossref","unstructured":"Bentrem DJ, Dematteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med\u20082005; 56: 139\u201356.","DOI":"10.1146\/annurev.med.56.082103.104630"},{"key":"2022061623212553400_B3","doi-asserted-by":"crossref","unstructured":"Mayer-Kuckuk P, Banerjee D, Kemeny N, Fong Y, Bertino JR. Molecular therapies for colorectal cancer metastatic to the liver. Mol Ther\u20082002; 5: 492\u2013500.","DOI":"10.1006\/mthe.2002.0596"},{"key":"2022061623212553400_B4","doi-asserted-by":"crossref","unstructured":"Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg\u20081984; 199: 502\u20138.","DOI":"10.1097\/00000658-198405000-00002"},{"key":"2022061623212553400_B5","doi-asserted-by":"crossref","unstructured":"Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet\u20082000; 355: 1041\u20137.","DOI":"10.1016\/S0140-6736(00)02034-1"},{"key":"2022061623212553400_B6","doi-asserted-by":"crossref","unstructured":"Kohne CH, van Cutsem E, Wils J, et al. Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. J Clin Oncol\u20082005; 23: 4856\u201365.","DOI":"10.1200\/JCO.2005.05.546"},{"key":"2022061623212553400_B7","doi-asserted-by":"crossref","unstructured":"Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med\u20082000; 343: 905\u201314.","DOI":"10.1056\/NEJM200009283431302"},{"key":"2022061623212553400_B8","doi-asserted-by":"crossref","unstructured":"de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol\u20082000; 18: 2938\u201347.","DOI":"10.1200\/JCO.2000.18.16.2938"},{"key":"2022061623212553400_B9","doi-asserted-by":"crossref","unstructured":"Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol\u20082004; 22: 1209\u201314.","DOI":"10.1200\/JCO.2004.11.037"},{"key":"2022061623212553400_B10","doi-asserted-by":"crossref","unstructured":"Block A, Freund CT, Chen SH, et al. Gene therapy of metastatic colon carcinoma: regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase. Cancer Gene Ther\u20082000; 7: 438\u201345.","DOI":"10.1038\/sj.cgt.7700131"},{"key":"2022061623212553400_B11","doi-asserted-by":"crossref","unstructured":"Chen SH, Chen XH, Wang Y, et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci U S A\u20081995; 92: 2577\u201381.","DOI":"10.1073\/pnas.92.7.2577"},{"key":"2022061623212553400_B12","doi-asserted-by":"crossref","unstructured":"Nyati MK, Symon Z, Kievit E, et al. The potential of 5-fluorocytosine\/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Ther\u20082002; 9: 844\u20139.","DOI":"10.1038\/sj.gt.3301706"},{"key":"2022061623212553400_B13","unstructured":"Zhang M, Li S, Nyati MK, et al. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model. Cancer Res\u20082003; 63: 658\u201363."},{"key":"2022061623212553400_B14","doi-asserted-by":"crossref","unstructured":"Sung MW, Yeh HC, Thung SN, et al. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial. Mol Ther\u20082001; 4: 182\u201391.","DOI":"10.1006\/mthe.2001.0444"},{"key":"2022061623212553400_B15","doi-asserted-by":"crossref","unstructured":"Dalba C, Klatzmann D, Logg CR, Kasahara N. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors. Curr Gene Ther\u20082005; 5: 655\u201367.","DOI":"10.2174\/156652305774964659"},{"key":"2022061623212553400_B16","doi-asserted-by":"crossref","unstructured":"Parato KA, Senger D, Forsyth PA, Bell JC. Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer\u20082005; 5: 965\u201376.","DOI":"10.1038\/nrc1750"},{"key":"2022061623212553400_B17","doi-asserted-by":"crossref","unstructured":"Sze DY, Freeman SM, Slonim SM, et al. Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival. J Vasc Interv Radiol\u20082003; 14: 279\u201390.","DOI":"10.1097\/01.RVI.0000058422.01661.1E"},{"key":"2022061623212553400_B18","unstructured":"Reid T, Galanis E, Abbruzzese J, et al. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints. Cancer Res\u20082002; 62: 6070\u20139."},{"key":"2022061623212553400_B19","doi-asserted-by":"crossref","unstructured":"Logg CR, Kasahara N. Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo. Methods Mol Biol\u20082004; 246: 499\u2013525.","DOI":"10.1385\/1-59259-650-9:499"},{"key":"2022061623212553400_B20","doi-asserted-by":"crossref","unstructured":"Logg CR, Logg A, Matusik RJ, Bochner BH, Kasahara N. Tissue-specific transcriptional targeting of a replication-competent retroviral vector. J Virol\u20082002; 76: 12783\u201391.","DOI":"10.1128\/JVI.76.24.12783-12791.2002"},{"key":"2022061623212553400_B21","doi-asserted-by":"crossref","unstructured":"Logg CR, Logg A, Tai CK, Cannon PM, Kasahara N. Genomic stability of murine leukemia viruses containing insertions at the Env-3\u2032 untranslated region boundary. J Virol\u20082001; 75: 6989\u201398.","DOI":"10.1128\/JVI.75.15.6989-6998.2001"},{"key":"2022061623212553400_B22","doi-asserted-by":"crossref","unstructured":"Logg CR, Tai CK, Logg A, Anderson WF, Kasahara N. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors. Hum Gene Ther\u20082001; 12: 921\u201332.","DOI":"10.1089\/104303401750195881"},{"key":"2022061623212553400_B23","doi-asserted-by":"crossref","unstructured":"Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol\u20081990; 10: 4239\u201342.","DOI":"10.1128\/MCB.10.8.4239"},{"key":"2022061623212553400_B24","doi-asserted-by":"crossref","unstructured":"Habib NA, Sarraf CE, Mitry RR, et al. E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors. Hum Gene Ther\u20082001; 12: 219\u201326.","DOI":"10.1089\/10430340150218369"},{"key":"2022061623212553400_B25","doi-asserted-by":"crossref","unstructured":"Sagawa T, Takahashi M, Sato T, et al. Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1\u201355K-deleted adenovirus with E1A expressed by CEA promoter. Mol Ther\u20082004; 10: 1043\u201350.","DOI":"10.1016\/j.ymthe.2004.08.023"},{"key":"2022061623212553400_B26","doi-asserted-by":"crossref","unstructured":"Kooby DA, Carew JF, Halterman MW, et al. Oncolytic viral therapy for human colorectal cancer and liver metastases using a multimutated herpes simplex virus type-1 (G207). FASEB J\u20081999; 13: 1325\u201334.","DOI":"10.1096\/fasebj.13.11.1325"},{"key":"2022061623212553400_B27","doi-asserted-by":"crossref","unstructured":"Reinblatt M, Pin RH, Federoff HJ, Fong Y. Utilizing tumor hypoxia to enhance oncolytic viral therapy in colorectal metastases. Ann Surg\u20082004; 239: 892\u20139;discussion 899\u2013902.","DOI":"10.1097\/01.sla.0000128308.36393.38"},{"key":"2022061623212553400_B28","doi-asserted-by":"crossref","unstructured":"Reinblatt M, Pin RH, Fong Y. Carcinoembryonic antigen directed herpes viral oncolysis improves selectivity and activity in colorectal cancer. Surgery\u20082004; 136: 579\u201384.","DOI":"10.1016\/j.surg.2004.05.033"},{"key":"2022061623212553400_B29","unstructured":"Gnant MF, Puhlmann M, Alexander HR, Jr., Bartlett DL. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice. Cancer Res\u20081999; 59: 3396\u2013403."},{"key":"2022061623212553400_B30","doi-asserted-by":"crossref","unstructured":"Gnant MF, Puhlmann M, Bartlett DL, Alexander HR, Jr. Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases. Ann Surg\u20081999; 230: 352\u201360.","DOI":"10.1097\/00000658-199909000-00008"},{"key":"2022061623212553400_B31","doi-asserted-by":"crossref","unstructured":"Tai CK, Wang WJ, Chen TC, Kasahara N. Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther\u20082005; 12: 842\u201351.","DOI":"10.1016\/j.ymthe.2005.03.017"},{"key":"2022061623212553400_B32","doi-asserted-by":"crossref","unstructured":"Wang WJ, Tai CK, Kasahara N, Chen TC. Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors. Hum Gene Ther\u20082003; 14: 117\u201327.","DOI":"10.1089\/104303403321070810"},{"key":"2022061623212553400_B33","doi-asserted-by":"crossref","unstructured":"Hiraoka K, Kimura T, Logg CR, Kasahara N. Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector. Clin Cancer Res\u20082006; 12: 7108\u201316.","DOI":"10.1158\/1078-0432.CCR-06-1452"},{"key":"2022061623212553400_B34","doi-asserted-by":"crossref","unstructured":"Humphreys MJ, Ghaneh P, Greenhalf W, et al. Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases. Gene Ther\u20082001; 8: 1241\u20137.","DOI":"10.1038\/sj.gt.3301518"},{"key":"2022061623212553400_B35","unstructured":"Nyati MK, Sreekumar A, Li S, et al. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res\u20082002; 62: 2337\u201342."},{"key":"2022061623212553400_B36","doi-asserted-by":"crossref","unstructured":"Stoeltzing O, Liu W, Reinmuth N, et al. Inhibition of integrin \u03b15\u03b21 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int J Cancer\u20082003; 104: 496\u2013503.","DOI":"10.1002\/ijc.10958"},{"key":"2022061623212553400_B37","doi-asserted-by":"crossref","unstructured":"Cannon PM, Kim N, Kingsman SM, Kingsman AJ. Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy. J Virol\u20081996; 70: 8234\u201340.","DOI":"10.1128\/jvi.70.11.8234-8240.1996"},{"key":"2022061623212553400_B38","doi-asserted-by":"crossref","unstructured":"Stripecke R, Koya RC, Ta HQ, Kasahara N, Levine AM. The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. Blood Cells Mol Dis\u20082003; 31: 28\u201337.","DOI":"10.1016\/S1079-9796(03)00062-7"},{"key":"2022061623212553400_B39","doi-asserted-by":"crossref","unstructured":"Mitsuya H, Broder S. Strategies for antiviral therapy in AIDS. Nature\u20081987; 325: 773\u20138.","DOI":"10.1038\/325773a0"},{"key":"2022061623212553400_B40","doi-asserted-by":"crossref","unstructured":"Thorne SH, Negrin RS, Contag CH. Synergistic antitumor effects of immune cell-viral biotherapy. Science\u20082006; 311: 1780\u20134.","DOI":"10.1126\/science.1121411"},{"key":"2022061623212553400_B41","doi-asserted-by":"crossref","unstructured":"Chan JK, Hamilton CA, Cheung MK, et al. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res\u20082006; 12: 1859\u201367.","DOI":"10.1158\/1078-0432.CCR-05-2019"},{"key":"2022061623212553400_B42","doi-asserted-by":"crossref","unstructured":"Drake JM, Gabriel CL, Henry MD. Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging. Clin Exp Metastasis\u20082005; 22: 674\u201384.","DOI":"10.1007\/s10585-006-9011-4"},{"key":"2022061623212553400_B43","doi-asserted-by":"crossref","unstructured":"Smakman N, Martens A, Kranenburg O, Borel Rinkes IH. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res\u20082004; 122: 225\u201330.","DOI":"10.1016\/j.jss.2004.05.021"},{"key":"2022061623212553400_B44","doi-asserted-by":"crossref","unstructured":"Tanji H, Yahata H, Hayamizu K, et al. Augmentation of local antitumor immunity in liver by interleukin-2 gene transfer via portal vein. Cancer Gene Ther\u20082002; 9: 655\u201364.","DOI":"10.1038\/sj.cgt.7700483"},{"key":"2022061623212553400_B45","doi-asserted-by":"crossref","unstructured":"Sova P, Ren XW, Ni S, et al. A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. Mol Ther\u20082004; 9: 496\u2013509.","DOI":"10.1016\/j.ymthe.2003.12.008"},{"key":"2022061623212553400_B46","doi-asserted-by":"crossref","unstructured":"Shinozaki K, Ebert O, Woo SL. Treatment of multifocal colorectal carcinoma metastatic to the liver of immune-competent and syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus. Int J Cancer\u20082005; 114: 659\u201364.","DOI":"10.1002\/ijc.20772"},{"key":"2022061623212553400_B47","doi-asserted-by":"crossref","unstructured":"Solly SK, Trajcevski S, Frisen C, et al. Replicative retroviral vectors for cancer gene therapy. Cancer Gene Ther\u20082003; 10: 30\u20139.","DOI":"10.1038\/sj.cgt.7700521"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/11\/5345\/2862961\/5345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/11\/5345\/2862961\/5345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:51:01Z","timestamp":1655434261000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/11\/5345\/533182\/Therapeutic-Efficacy-of-Replication-Competent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2007,6,1]]},"published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4673","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}